Health-related quality of life as a predictor of tuberculosis treatment outcomes in Iraq
Author | Dujaili, Juman Abdulelah |
Author | Sulaiman, Syed Azhar Syed |
Author | Hassali, Mohamed Azmi |
Author | Awaisu, Ahmed |
Author | Blebil, Ali Qais |
Author | Bredle, Jason M. |
Available date | 2016-09-22T09:46:20Z |
Publication Date | 2015-02 |
Publication Name | International Journal of Infectious Diseases |
Identifier | http://dx.doi.org/10.1016/j.ijid.2014.12.004 |
Citation | Juman Abdulelah Dujaili, Syed Azhar Syed Sulaiman, Mohamed Azmi Hassali, Ahmed Awaisu, Ali Qais Blebil, Jason M. Bredle, Health-related quality of life as a predictor of tuberculosis treatment outcomes in Iraq, International Journal of Infectious Diseases, Volume 31, February 2015, Pages 4-8 |
ISSN | 1201-9712 |
Abstract | Summary ObjectivesTo determine how tuberculosis (TB) treatment affects the health-related quality of life (HRQL) of patients with pulmonary TB and to identify the predictors of favourable TB treatment outcomes in Baghdad, Iraq. MethodsThe Functional Assessment of Chronic Illness Therapy – Tuberculosis (FACIT-TB), a new TB-specific quality of life instrument derived from the internationally recognized FACIT measurement system for the assessment of HRQL, was administered. The mean total and subscale scores of the FACIT-TB at baseline, end of the intensive phase, and end of TB treatment were compared. ResultsAfter the 2-month intensive phase, physical well-being, functional well-being, and the overall total scores were significantly increased (p<0.01). Furthermore, at completion of TB treatment, there were significant improvements in the overall HRQL as indicated by the FACIT-TB total score and all subscales, except social and economic well-being and spiritual well-being. In a direct logistic regression model, only the FACIT-TB total score made a statistically significant contribution towards predicting the likelihood that a patient would have a favourable TB treatment outcome. ConclusionsTherapeutic intervention had a positive impact on patient HRQL. We conclude that FACIT-TB is a reliable tool to monitor HRQL during the course of TB treatment. |
Sponsor | Universiti Sains Malaysia, Research University Postgraduate Research Grant Scheme (USM-RU-PRGS; grant number 1001/PFARMASI/845040). |
Language | en |
Publisher | Elsevier, Ltd |
Subject | Tuberculosis Treatment Outcome HRQL FACIT FACT-G |
Type | Article |
Pagination | 4-8 |
Volume Number | 31 |
Open Access user License | http://creativecommons.org/licenses/by-nc-nd/3.0/ |
Check access options
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Research [1357 items ]